Contact
QR code for the current URL

Story Box-ID: 256855

Xenios AG Im Zukunftspark 1 74076 Heilbronn, Germany http://www.xenios-ag.com
Contact Ms Franziska Preissing +49 7133 9011130
Company logo of Xenios AG

Novalung signs Carestream Medical, Inc., as exclusive distributor in Canada

Company intensifies its North American marketing activities to meet increasing demand in the Canadian market

(PresseBox) (Talheim, )
Novalung GmbH, the German manufacturer of the innovative iLA Membrane Ventilator® for extrapulmonary lung support, is pleased to announce that it has appointed Carestream Medical, Inc., as its exclusive distributor in Canada. "Carestream is uniquely positioned to represent our products in the Canadian market", said Dr. Georg Matheis, CEO of Novalung. "With their highly skilled team of respiratory-care specialists and their clinical expertise, they will be able to build on the Canadian experience with the iLA Membrane Ventilator® in lung transplant surgery and bring the benefits of extrapulmonary lung support to a much broader range of patients on mechanical ventilation."

Shawn Nicol, National Sales Manager for Carestream Medical, said "We are thrilled to have added Novalung's product line to our current range of leading-edge medical technologies. As respiratory therapists, we understand the benefit of advancing current 'protective ventilation' strategies towards true lung protection using the iLA Membrane Ventilator®."

iLA Membrane Ventilator® has helped Canadian patients

In Canada, the iLA Membrane Ventilator® is currently best known for its successful role in treating patients at Toronto General Hospital and The Hospital for Sick Children as part of their lung transplantation programmes.

Background information on Carestream Medical, Inc.

Carestream Medical Ltd. was founded in 1997 and represents a broad range of respiratory-care, anesthesia and intensive-care products throughout Canada, with offices in Coquitlam (BC) and Pickering (ON). Carestream is in the top 200 of the fastest growing companies in Canada based on the previous five fiscal years.

Attachments

Xenios AG

Driver of a paradigm shift

Novalung is a German company which develops, produces and markets innovative solutions for lung failure, including the world’s first pumpless artificial lung assist device designed specifically to breathe outside the patient’s body. The iLA Membrane Ventilator® supports the lung by removing carbon dioxide directly from the blood, reducing the work load for the patient’s own lung. Use of the iLA Membrane Ventilator® thus permits adequate ventilation irrespective of lung function, and allows lung-protective parameters on the respirator to be used without the limitations usually imposed by the need for pulmonary gas exchange. The iLA Membrane Ventilator® is driven by the human heart like a natural organ, without the need for external blood pumps, and has been used to support patients’ lungs in over 4,000 cases of ARDS, ALI, pneumonia, exacerbated COPD, trauma and lung transplantation.

The iLA Membrane Ventilator® is connected non-surgically to a femoral (groin) artery and vein using two specially designed NovaPort® vascular access devices. The artificial lung itself measures only 14x14 cm. Inside, a hollow fibre membrane takes over the function of the pulmonary alveoli and thus supports or in some cases even replaces common mechanical ventilation. So-called “protective” ventilation strategies can now be pursued more aggressively; the patient’s natural lung is given „Time to Heal“®. The iLA Membrane Ventilator® is approved for temporary use up to 29 days for patients in intensive care units.

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.